Lataa...
Early phase clinical trials—are dose expansion cohorts needed?
Dose-expansion cohorts (DECs) enable investigators to identify potentially effective drugs, for specific patient populations, in a single trial by assessing antitumour activity as early as possible. We discuss how the objectives, design and interpretation of DEC have evolved, and how DECs are changi...
Tallennettuna:
| Julkaisussa: | Nat Rev Clin Oncol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4758199/ https://ncbi.nlm.nih.gov/pubmed/26441082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrclinonc.2015.174 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|